{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:01:00Z","timestamp":1793030460523,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7664","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/nature23270","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T12:04:51Z","timestamp":1500379491000},"page":"413-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1098,"title":["In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target"],"prefix":"10.1038","volume":"547","author":[{"given":"Robert T.","family":"Manguso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans W.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret D.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavian D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen B.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie B.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"LaFleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram R.","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Van Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Root","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene H.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Doench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Nicholas","family":"Haining","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"BFnature23270_CR1","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck, M. et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N. Engl. J. Med. 375, 1823\u20131833 (2016)","journal-title":"N. Engl. J. Med."},{"key":"BFnature23270_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/NEJMoa1302369","volume":"369","author":"JD Wolchok","year":"2013","unstructured":"Wolchok, J. D. et al. Nivolumab plus ipilimumab in advanced melanoma. N. Engl. J. Med. 369, 122\u2013133 (2013)","journal-title":"N. Engl. J. Med."},{"key":"BFnature23270_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky, J. M. et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375, 819\u2013829 (2016)","journal-title":"N. Engl. J. Med."},{"key":"BFnature23270_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793\u2013800 (2002)","journal-title":"Nat. Med."},{"key":"BFnature23270_CR5","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20130066","volume":"210","author":"RB Holmgaard","year":"2013","unstructured":"Holmgaard, R. B., Zamarin, D., Munn, D. H., Wolchok, J. D. & Allison, J. P. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4. J. Exp. Med. 210, 1389\u20131402 (2013)","journal-title":"J. Exp. Med."},{"key":"BFnature23270_CR6","doi-asserted-by":"publisher","first-page":"11103","DOI":"10.1073\/pnas.1305569110","volume":"110","author":"D Tseng","year":"2013","unstructured":"Tseng, D. et al. Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc. Natl Acad. Sci. USA 110, 11103\u201311108 (2013)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature23270_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","volume":"18","author":"GL Sica","year":"2003","unstructured":"Sica, G. L. et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 18, 849\u2013861 (2003)","journal-title":"Immunity"},{"key":"BFnature23270_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1101\/sqb.2016.81.031070","volume":"81","author":"TP Howard","year":"2016","unstructured":"Howard, T. P. et al. Functional genomic characterization of cancer genomes. Cold Spring Harb. Symp. Quant. Biol. 81, 237\u2013246 (2016)","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"BFnature23270_CR9","doi-asserted-by":"publisher","first-page":"140035","DOI":"10.1038\/sdata.2014.35","volume":"1","author":"GS Cowley","year":"2014","unstructured":"Cowley, G. S. et al. Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. Sci. Data 1, 140035 (2014)","journal-title":"Sci. Data"},{"key":"BFnature23270_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem, O. et al. Genome-scale CRISPR\u2013Cas9 knockout screening in human cells. Science 343, 84\u201387 (2014)","journal-title":"Science"},{"key":"BFnature23270_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","volume":"163","author":"T Hart","year":"2015","unstructured":"Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515\u20131526 (2015)","journal-title":"Cell"},{"key":"BFnature23270_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","volume":"160","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246\u20131260 (2015)","journal-title":"Cell"},{"key":"BFnature23270_CR13","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1038\/sj.onc.1206459","volume":"22","author":"G Dranoff","year":"2003","unstructured":"Dranoff, G. GM-CSF-secreting melanoma vaccines. Oncogene 22, 3188\u20133192 (2003)","journal-title":"Oncogene"},{"key":"BFnature23270_CR14","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1073\/pnas.90.8.3539","volume":"90","author":"G Dranoff","year":"1993","unstructured":"Dranoff, G. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl Acad. Sci. USA 90, 3539\u20133543 (1993)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature23270_CR15","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1158\/0008-5472.CAN-12-4100","volume":"73","author":"J Duraiswamy","year":"2013","unstructured":"Duraiswamy, J., Kaluza, K. M., Freeman, G. J. & Coukos, G. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res. 73, 3591\u20133603 (2013)","journal-title":"Cancer Res."},{"key":"BFnature23270_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/eji.200324432","volume":"34","author":"H Wada","year":"2004","unstructured":"Wada, H., Matsumoto, N. & Maenaka, K., Suzuki, K. & Yamamoto, K. The inhibitory NK cell receptor CD94\/NKG2A and the activating receptor CD94\/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur. J. Immunol. 34, 81\u201390 (2004)","journal-title":"Eur. J. Immunol."},{"key":"BFnature23270_CR17","doi-asserted-by":"publisher","first-page":"7090","DOI":"10.1182\/blood-2010-10-314286","volume":"117","author":"M Kleppe","year":"2011","unstructured":"Kleppe, M. et al. PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia. Blood 117, 7090\u20137098 (2011)","journal-title":"Blood"},{"key":"BFnature23270_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/ng.587","volume":"42","author":"M Kleppe","year":"2010","unstructured":"Kleppe, M. et al. Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia. Nat. Genet. 42, 530\u2013535 (2010)","journal-title":"Nat. Genet."},{"key":"BFnature23270_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cyto.2015.12.025","volume":"82","author":"KA Pike","year":"2016","unstructured":"Pike, K. A. & Tremblay, M. L. TC-PTP and PTP1B: regulating JAK\u2013STAT signaling, controlling lymphoid malignancies. Cytokine 82, 52\u201357 (2016)","journal-title":"Cytokine"},{"key":"BFnature23270_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ng2068","volume":"39","author":"JA Todd","year":"2007","unstructured":"Todd, J. A. et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 39, 857\u2013864 (2007)","journal-title":"Nat. Genet."},{"key":"BFnature23270_CR21","doi-asserted-by":"crossref","unstructured":"Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661\u2013678 (2007)","DOI":"10.1038\/nature05911"},{"key":"BFnature23270_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3389\/fimmu.2014.00394","volume":"5","author":"F Morandi","year":"2014","unstructured":"Morandi, F. & Pistoia, V. Interactions between HLA-G and HLA-E in physiological and pathological conditions. Front. Immunol. 5, 394 (2014)","journal-title":"Front. Immunol."},{"key":"BFnature23270_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1479-5876-9-184","volume":"9","author":"M Benevolo","year":"2011","unstructured":"Benevolo, M. et al. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis. J. Transl. Med. 9, 184 (2011)","journal-title":"J. Transl. Med."},{"key":"BFnature23270_CR24","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.18632\/oncotarget.6506","volume":"7","author":"M Talebian Yazdi","year":"2016","unstructured":"Talebian Yazdi, M. et al. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma. Oncotarget 7, 3477\u20133488 (2016)","journal-title":"Oncotarget"},{"key":"BFnature23270_CR25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.4049\/jimmunol.182.2.829","volume":"182","author":"A S\u00e1ez-Border\u00edas","year":"2009","unstructured":"S\u00e1ez-Border\u00edas, A. et al. IL-12-dependent inducible expression of the CD94\/NKG2A inhibitory receptor regulates CD94\/NKG2C+ NK cell function. J. Immunol. 182, 829\u2013836 (2009)","journal-title":"J. Immunol."},{"key":"BFnature23270_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ni757","volume":"3","author":"JM Moser","year":"2002","unstructured":"Moser, J. M., Gibbs, J., Jensen, P. E. & Lukacher, A. E. CD94-NKG2A receptors regulate antiviral CD8+ T cell responses. Nat. Immunol. 3, 189\u2013195 (2002)","journal-title":"Nat. Immunol."},{"key":"BFnature23270_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/ni1063","volume":"5","author":"D Hu","year":"2004","unstructured":"Hu, D. et al. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5, 516\u2013523 (2004)","journal-title":"Nat. Immunol."},{"key":"BFnature23270_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrm3683","volume":"14","author":"D Ofengeim","year":"2013","unstructured":"Ofengeim, D. & Yuan, J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat. Rev. Mol. Cell Biol. 14, 727\u2013736 (2013)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnature23270_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature06494","volume":"451","author":"BL Ebert","year":"2008","unstructured":"Ebert, B. L. et al. Identification of RPS14 as a 5q\u2212 syndrome gene by RNA interference screen. Nature 451, 335\u2013339 (2008)","journal-title":"Nature"},{"key":"BFnature23270_CR30","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","volume":"26","author":"ML Broz","year":"2014","unstructured":"Broz, M. L. et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell 26, 638\u2013652 (2014)","journal-title":"Cancer Cell"},{"key":"BFnature23270_CR31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nbt.3026","volume":"32","author":"JG Doench","year":"2014","unstructured":"Doench, J. G. et al. Rational design of highly active sgRNAs for CRISPR\u2013Cas9-mediated gene inactivation. Nat. Biotechnol. 32, 1262\u20131267 (2014)","journal-title":"Nat. Biotechnol."},{"key":"BFnature23270_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015)","journal-title":"Cell Syst."},{"key":"BFnature23270_CR33","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature23270_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","volume":"5","author":"AB Olshen","year":"2004","unstructured":"Olshen, A. B., Venkatraman, E. S., Lucito, R. & Wigler, M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5, 557\u2013572 (2004)","journal-title":"Biostatistics"},{"key":"BFnature23270_CR35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207\u2013211 (2015)","journal-title":"Science"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature23270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature23270","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nature23270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nature23270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T14:03:34Z","timestamp":1684418614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature23270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":35,"journal-issue":{"issue":"7664","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFnature23270"],"URL":"https:\/\/doi.org\/10.1038\/nature23270","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727819093.793543387","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.727819093.793536207","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"8 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}